HealthCare Global Q2 FY27 consolidated revenue Rs 730.16 cr; PAT Rs 9.25 cr

What the numbers show

• Net margin was 1.27% of revenue, down 193 bps from 3.20%.
• Revenue rose 13.2% while total expenses rose 11.9%.

• Revenue from operations (consolidated): Rs 730.16 cr in the quarter ended 30 September 2026 vs Rs 645.16 cr in the corresponding quarter ended 30 September 2025 (statement of financial results, consolidated).

• Total income: Rs 733.71 cr vs Rs 649.47 cr a year earlier.

• Total expenses: Rs 704.63 cr vs Rs 629.96 cr a year earlier.

• Finance costs: Rs 38.42 cr vs Rs 43.62 cr a year earlier.

• Depreciation and amortisation expense: Rs 67.80 cr vs Rs 62.80 cr a year earlier.

• Other expenses: Rs 129.00 cr vs Rs 115.61 cr a year earlier.

• Profit before share of profit/(loss) of joint venture, exceptional items and tax: Rs 29.08 cr vs Rs 19.51 cr a year earlier.

• Share of profit/(loss) of joint venture: Rs 1.00 cr vs Rs 0.31 cr a year earlier.

• Profit before exceptional items and tax: Rs 30.08 cr vs Rs 19.82 cr a year earlier.

• Exceptional item: Rs (11.59) cr vs Rs - in the year-ago quarter.

• Profit/(loss) before tax: Rs 18.49 cr vs Rs 19.82 cr a year earlier.

• Total tax expense/(credit): Rs 9.24 cr vs Rs (0.84) cr a year earlier.

• Profit/(loss) for the period / year (PAT): Rs 9.25 cr vs Rs 20.66 cr a year earlier.

• Earnings per share – Basic: Rs 0.32 vs Rs 1.15 a year earlier.

• Earnings per share – Diluted: Rs 0.32 vs Rs 1.15 a year earlier.

In the consolidated statement of financial results for the quarter ended 30 September 2026, HealthCare Global Enterprises Limited reported revenue from operations of Rs 730.16 cr, higher than the Rs 645.16 cr reported in the corresponding quarter ended 30 September 2025. Total income, which includes income from government grant and other income, increased to Rs 733.71 cr from Rs 649.47 cr over the same period.

Total expenses rose to Rs 704.63 cr from Rs 629.96 cr a year earlier, driven by higher purchases of medical and non-medical items at Rs 190.22 cr (vs Rs 181.22 cr), employee benefits expense at Rs 114.48 cr (vs Rs 94.18 cr), medical consultancy charges at Rs 160.74 cr (vs Rs 136.60 cr) and other expenses at Rs 129.00 cr (vs Rs 115.61 cr). Finance costs declined to Rs 38.42 cr from Rs 43.62 cr, while depreciation and amortisation expense increased to Rs 67.80 cr from Rs 62.80 cr.

Profit before share of profit/(loss) of joint venture, exceptional items and tax improved to Rs 29.08 cr from Rs 19.51 cr in the year-ago quarter. After including share of profit of joint venture of Rs 1.00 cr (vs Rs 0.31 cr), profit before exceptional items and tax stood at Rs 30.08 cr compared with Rs 19.82 cr a year earlier. The current quarter includes an exceptional item of Rs (11.59) cr, against no exceptional item in the corresponding quarter. Profit/(loss) before tax was Rs 18.49 cr versus Rs 19.82 cr a year earlier.

Total tax expense was Rs 9.24 cr in the quarter, compared with a tax credit of Rs (0.84) cr in the same quarter last year. Profit/(loss) for the period / year (profit after tax attributable to the group as a whole) came in at Rs 9.25 cr, down from Rs 20.66 cr a year earlier. Basic earnings per share for the quarter were Rs 0.32, compared with Rs 1.15 in the corresponding quarter, with diluted earnings per share also at Rs 0.32 versus Rs 1.15 a year earlier, as per the consolidated statement of financial results.